Reduction of menstrual blood loss in women suffering from idiopathic menorrhagia with a novel antifibrinolytic drug (Kabi 2161)

British Journal of Obstetrics and Gynaecology
M EdlundB von Schoultz

Abstract

To compare the effect of Kabi 2161 (a prodrug of tranexamic acid) and placebo on the reduction of menstrual blood loss in women suffering from idiopathic menorrhagia and to evaluate tolerance and effectiveness in a two-dose regimen. A randomised, double blind parallel group study using double dummy technique. The departments of gynaecology at three medical centres in Sweden. Ninety-one outpatients visiting the gynaecological clinics from March 1991 to May 1992 were randomised into the study; 68 women fulfilled the study. Two run-in cycles, followed by administrations of Kabi 2161 (600 mg) tablets (1 four times daily or 2 twice daily) or placebo for the first five days of three menstrual cycles. Objective measurement of the change in menstrual blood loss during the treatment periods compared with menstrual blood loss during the run-in periods. A statistically significant reduction of menstrual blood loss was found for each treatment group, compared with the placebo group (P < 0.001). The mean reduction with 95% confidence interval (CI) was 33% (24-40) in the group treated with 1 four times daily and 41% (33-49) in the group treated 2 twice daily. The difference between the treated groups in reduction of menstrual blood loss is n...Continue Reading

References

Feb 1, 1992·Drugs·M A van EijkerenJ J Sixma
Jun 1, 1989·Baillière's Clinical Obstetrics and Gynaecology·M C Rees
Jan 1, 1988·Acta Obstetricia Et Gynecologica Scandinavica·B AnderschG Rybo
Jan 1, 1987·Scandinavian Journal of Gastroenterology. Supplement·B Astedt
Oct 24, 1970·British Medical Journal·S T CallenderE Cope
Oct 1, 1971·The Journal of Obstetrics and Gynaecology of the British Commonwealth·S K ColeA M Thomson
Jan 1, 1966·Acta Obstetricia Et Gynecologica Scandinavica·L HallbergG Rybo
Jan 1, 1966·Acta Obstetricia Et Gynecologica Scandinavica·G Rybo
Aug 1, 1984·American Journal of Obstetrics and Gynecology·I S FraserR Markham
Feb 18, 1981·Biochimica Et Biophysica Acta·M HoylaertsD Collen
Jan 1, 1981·European Journal of Clinical Pharmacology·A PilbrantJ Vessman
Jan 1, 1964·Scandinavian Journal of Clinical and Laboratory Investigation·L HALLBERG, L NILSSON

❮ Previous
Next ❯

Citations

Dec 1, 1996·American Journal of Hematology·M EdlundO Andersson
Jul 15, 2009·Journal de gynécologie, obstétrique et biologie de la reproduction·O Graesslin, E Derniaux
Sep 24, 2011·Journal of Women's Health·Måns Edlund
Jan 26, 2011·Thrombosis Research·Claire S Philipp
Aug 10, 2015·American Journal of Obstetrics and Gynecology·Linda D Bradley, Ndeye-Aicha Gueye
Aug 1, 2007·Journal of Thrombosis and Haemostasis : JTH·P A Kouides, R A Kadir
Jan 11, 2012·Acta Obstetricia Et Gynecologica Scandinavica·Becky Naoulou, Ming C Tsai
Nov 9, 2005·Fertility and Sterility·Rezan A KadirJenny Goudemand
Jul 23, 2011·American Journal of Obstetrics and Gynecology·Ellen W FreemanTammie L Adomako
Feb 7, 2006·American Journal of Obstetrics and Gynecology·Jonathan ShowstackUNKNOWN Ms Research Group
Jun 17, 2000·Obstetrics and Gynecology Clinics of North America·M G Munro
Apr 16, 2018·The Cochrane Database of Systematic Reviews·Alison C Bryant-SmithMartha Hickey
May 3, 2013·Obstetrics and Gynecology·Kristen A MattesonUNKNOWN Society of Gynecologic Surgeons Systematic Review Group
Apr 17, 2004·The Journal of Family Planning and Reproductive Health Care·Joanne Protheroe
Oct 1, 1996·British Journal of Obstetrics and Gynaecology·M J GannonN Johnson
Jan 14, 2004·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Samendra Nath Roy, Siladitya Bhattacharya
Sep 23, 2010·Obstetrics and Gynecology·Andrea S LukesGary A Shangold
Nov 2, 2002·Haemophilia : the Official Journal of the World Federation of Hemophilia·R A KadirD L Economides
Feb 12, 2015·Obstetrical & Gynecological Survey·Johannes BitzerIan S Fraser
May 20, 2003·Acta Obstetricia Et Gynecologica Scandinavica·M K Oehler, M C P Rees
Oct 18, 2000·The Cochrane Database of Systematic Reviews·A LethabyI Cooke

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.